Why Elanco Animal Health Is Drawing Investor Attention

Elanco Animal Health (ELAN) is back on investor radars after a period of strong share performance, with the stock showing positive returns over the past week, month and past 3 months.

At a share price of $25.13, Elanco’s recent 90 day share price return of 17.48% sits against a 1 year total shareholder return of 123.38% and a 3 year total shareholder return of 91.39%. This suggests momentum has been strong over both shorter and longer horizons.

If this kind of move has you looking beyond a single name, it could be a good moment to see what else is gaining traction through our screener of 23 top founder-led companies.

With Elanco trading at $25.13, sitting close to its average analyst price target yet showing an estimated 30% intrinsic discount, investors may ask whether there is still a buying opportunity here or whether the market is already pricing in future growth.

Most Popular Narrative: 3.1% Undervalued

Against the last close of $25.13, the most followed narrative points to a fair value of $25.92, with its case built around products and balance sheet changes.

Recent research coverage on Elanco Animal Health has leaned constructive, with several firms lifting price targets or initiating and upgrading ratings after reviewing the company’s new product pipeline, revenue initiatives and balance sheet trajectory.

Have a read of the narrative in full and understand what's behind the forecasts. Read the complete narrative.

Want to see what is backing that fair value call? The narrative focuses on anticipated pet health launches, margin rebuild from efficiency moves, and a richer earnings multiple that is contingent on those plans. The full write up connects those moving parts into a single valuation story.

Result: Fair Value of $25.92 (UNDERVALUED)

However, the story could change if FX headwinds or slower than expected uptake of new launches such as Zenrelia and Credelio Quattro weigh on revenue and margins.

Build Your Own Elanco Animal Health Narrative

If you see the story differently or just prefer to run the numbers yourself, you can build your own view in a few minutes: Do it your way.

A great starting point for your Elanco Animal Health research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.

Looking for more investment ideas?

If you are weighing your next move, do not stop at one company when there are targeted idea lists that can quickly broaden your watchlist.

• Spot potential value opportunities early by scanning our set of screener containing 24 high quality undiscovered gems and see which names stand out to you.
• Strengthen your focus on resilience with a curated group of 83 resilient stocks with low risk scores that keep risk scores front and center.
• Target quality with financial footing by checking stocks in our solid balance sheet and fundamentals stocks screener (44 results) and see which businesses match your comfort level.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.